设计一个高效,可预测的全球批准后变化管理系统的方法,以促进持续改进和药物产品的可用性
Anders Vinther1, Emma Ramnarine2, Thierry Gastineau3
1QBA - Quality Business Administration, San Carlos, CA, USA. anders@qbaleaders.com.
Therapeutic innovation & regulatory science
|February 18, 2024
概括
全球监管的复杂性大大推迟了批准后的变化 (PAC),影响了药物供应. 一项新的倡议为行业和监管机构提出了8种整体方法,以确保全球及时提供药物.
科学领域:
- 药品供应链管理的管理
- 全球监管事务全球监管事务
- 药物产品生命周期管理
背景情况:
- 全球药物产品供应链面临着日益复杂的局面,COVID-19疫情等事件加剧了这种局面.
- 审批后变更 (PAC) 对于产品生命周期管理至关重要,但受到复杂的全球监管环境的阻碍.
- 现有的管理全球PAC的方法已经被证明是不够的,导致严重的延迟和潜在的药物短缺.
研究的目的:
- 量化全球监管复杂性影响批准后变化的严重程度.
- 突出全球PAC管理的整体,协作式方法的关键需求.
- 提出可行的战略,以改变全球PAC管理系统.
主要方法:
- 在2019-2021年期间,分析了18家全球制药公司在156个国家提交的超过145,000份PAC申请.
- 纳入标准集中在需要国家监管机构 (NRA) 预先批准的PAC上.
- 与世卫组织建议的重大变化六个月审查期相比,对批准时间进行基准评估.
主要成果:
- 在156个国家中,只有一个国家在6个月的基准期内一致批准了PAC.
- 在6%的国家 (对于>10%的PAC) 和22%的国家 (对于>50%的PAC) 需要超过6个月才能获得PAC批准.
- 不同国家监管机构在批准时间表 (数月至5年) 中存在显著的变化,使全球同时批准变得罕见.
结论:
- 这些数据揭示了PAC管理的全球监管复杂性的严重和日益严重的问题.
- 迫切需要一个合作,整体的方法,涉及行业和监管机构,以确保全球药物产品的可用性.
- 该倡议提出了8个关键战略,以推动系统转型和减轻供应风险.
相关概念视频
Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Administration and Therapy Phases: Overview
465
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
465
Drug Control Governance: Regulatory Bodies and Their Impact
158
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
158
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K


